Clinical Studies of Phenylbutazone (Butazolidin) and Butapyrin (Irgapyrin) in Rheumatoid Arthritis, Rheumatoid Spondylitis, and Gout
Open Access
- 1 March 1953
- journal article
- research article
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 12 (1) , 20-24
- https://doi.org/10.1136/ard.12.1.20
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- AGRANULOCYTOSIS FOLLOWING USE OF PHENYLBUTAZONE (BUTAZOLIDIN9)JAMA, 1953
- AGRANULOCYTOSIS FOLLOWING ADMINISTRATION OF PHENYLBUTAZONE (BUTAZOLIDIN®)JAMA, 1953
- PHENYLBUTAZONE THERAPY OF ARTHRITIS AND OTHER PAINFUL MUSCULOSKELETAL DISORDERSJAMA, 1952
- BENEFITS AND TOXICITY OF PHENYLBUTAZONE (BUTAZOLIDIN®) IN RHEUMATOID ARTHRITISJAMA, 1952
- TREATMENT OF RHEUMATOID ARTHRITIS WITH BUTAZOLIDINEThe Lancet, 1952
- TREATMENT OF RHEUMATOID ARTHRITIS WITH BUTAZOLIDINEThe Lancet, 1952
- PHENYLBUTAZONE (BUTAZOLIDIN®) IN RHEUMATOID ARTHRITIS AND GOUTJAMA, 1952
- Diseases of Bones and JointsAnnual Review of Medicine, 1951
- Über Irgapyrin, ein neues Mittel zur parenteralen Pyrazoltherapie der rheumatischen PolyarthritisDeutsche Medizinische Wochenschrift (1946), 1951
- Histamin-antagonistische Wirkung bei Pyrazolen und AntihistaminenNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1950